134 related articles for article (PubMed ID: 23258383)
1. Characterizing phenotypes and outcomes of drug-associated liver injury using electronic medical record data.
Shin J; Hunt CM; Suzuki A; Papay JI; Beach KJ; Cheetham TC
Pharmacoepidemiol Drug Saf; 2013 Feb; 22(2):190-8. PubMed ID: 23258383
[TBL] [Abstract][Full Text] [Related]
2. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
3. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.
Björnsson ES; Bergmann OM; Björnsson HK; Kvaran RB; Olafsson S
Gastroenterology; 2013 Jun; 144(7):1419-25, 1425.e1-3; quiz e19-20. PubMed ID: 23419359
[TBL] [Abstract][Full Text] [Related]
4. A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.
Heidemann L; Law J; Fontana RJ
Dig Dis Sci; 2017 Mar; 62(3):615-625. PubMed ID: 26597192
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
Baekdal M; Ytting H; Skalshøi Kjær M
Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury.
Leise MD; Poterucha JJ; Talwalkar JA
Mayo Clin Proc; 2014 Jan; 89(1):95-106. PubMed ID: 24388027
[TBL] [Abstract][Full Text] [Related]
7. A proposed modification to Hy's law and Edish criteria in oncology clinical trials using aggregated historical data.
Parks D; Lin X; Painter JL; Cheng J; Hunt CM; Spraggs CF; Nelson JJ; Curtis L; Menius JA; Lee KR
Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):571-8. PubMed ID: 23300062
[TBL] [Abstract][Full Text] [Related]
8. An automated causality assessment algorithm to detect drug-induced liver injury in electronic medical record data.
Cheetham TC; Lee J; Hunt CM; Niu F; Reisinger S; Murray R; Powell G; Papay J
Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):601-8. PubMed ID: 24920207
[TBL] [Abstract][Full Text] [Related]
9. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
10. Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
Louissaint J; Kassab I; Yeboah-Korang A; Fontana RJ
Dig Dis Sci; 2022 Aug; 67(8):4243-4249. PubMed ID: 34427818
[TBL] [Abstract][Full Text] [Related]
11. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
[TBL] [Abstract][Full Text] [Related]
12. Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system.
Ulcickas Yood M; Bortolini M; Casso D; Beck JG; Oliveria SA; Wells KE; Woodcroft KJ; Wang LI
Pharmacoepidemiol Drug Saf; 2015 Apr; 24(4):427-34. PubMed ID: 25683797
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and incidence of liver enzyme elevations in a pooled oncology clinical trial cohort.
Shantakumar S; Landis S; Lawton A; Hunt CM
Regul Toxicol Pharmacol; 2016 Jun; 77():257-62. PubMed ID: 27025923
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.
Woo HJ; Kim HY; Choi ES; Cho YH; Kim Y; Lee JH; Jang E
Phytomedicine; 2015 Dec; 22(13):1201-5. PubMed ID: 26598920
[TBL] [Abstract][Full Text] [Related]
15. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience.
Idilman R; Bektas M; Cinar K; Toruner M; Cerit ET; Doganay B; Erden E; Bozkaya H; Bahar K; Karayalcin S; Soykan I; Palabiyikoglu M; Cetinkaya H; Yurdaydin C; Dokmeci A; Ozden A
J Clin Gastroenterol; 2010 Jul; 44(6):e128-32. PubMed ID: 20551776
[TBL] [Abstract][Full Text] [Related]
16. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M
Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470
[TBL] [Abstract][Full Text] [Related]
17. Dili is rare amongst patients without liver metastases receiving cancer treatment in Iceland: a population-based cohort study.
Björnsson HK; Sverrisdottir A; Björnsson ES
Scand J Gastroenterol; 2022 Jul; 57(7):856-861. PubMed ID: 35138984
[TBL] [Abstract][Full Text] [Related]
18. Incidence of drug-induced liver injury in medical inpatients.
Meier Y; Cavallaro M; Roos M; Pauli-Magnus C; Folkers G; Meier PJ; Fattinger K
Eur J Clin Pharmacol; 2005 Apr; 61(2):135-43. PubMed ID: 15726344
[TBL] [Abstract][Full Text] [Related]
19. An update on drug induced liver injury.
Rangnekar AS; Fontana RJ
Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
[TBL] [Abstract][Full Text] [Related]
20. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
